Assessing Contamination Profiles in Livers from Road-Killed Owls.

Raptors are recognized as valuable sentinel species for monitoring environmental contaminants owing to their foraging behavior across terrestrial and aquatic food webs and their high trophic position. The present study monitored environmental contaminants in livers from road-killed owls to evaluate differences in the exposure patterns due to factors such as species, age, and sex of individuals. Carcasses of road-killed individuals of eagle owl (Bubo bubo), long-eared owl (Asio otus), little owl (Athene noctua), tawny owl (Strix aluco), and barn owl (Tyto alba) were collected in Alentejo (Portugal). Eighty-one organic contaminants were analyzed, including organochlorine pesticides (OCPs), per- and polyfluoroalkyl substances (PFAS), polychlorinated biphenyls (PCBs), polycyclic aromatic hydrocarbons (PAHs), pharmaceuticals, in-use pesticides, and organophosphate esters (OPEs). Overall, 21 contaminants were detected. In all species ∑OCPs were prevalent at concentrations from 3.24 to 4480 ng/g wet weight, followed by perfluorooctane sulfonic acid (PFOS), the only PFASs detected (from 2.88 to 848 ng/g wet wt) and ∑PCBs (1.98-2010 ng/g wet wt); ∑PAHs were ubiquitous but detected at the lowest concentrations (7.35-123 ng/g wet wt). Differences among species were observed according to principal component analysis. Eagle owl and long-eared owl presented the highest levels of ∑OCPs, ∑PCBs, and PFOS, consistent with its higher trophic position, while ∑PAHs prevailed in tawny owl, barn owl, and little owl, related to their frequent use of urban areas for nesting and roadsides for hunting. Adults presented higher concentrations of ∑OCPs and ∑PCBs than juveniles, while no differences were observed for PFOS and ∑PAHs. Pharmaceuticals, in-use pesticides, and OPEs were not detected. Overall, the present study shows specific contamination patterns in five species with similar diet but with differences in habitat preferences. Environ Toxicol Chem 2024;43:821-832. © 2023 The Authors. Environmental Toxicology and Chemistry published by Wiley Periodicals LLC on behalf of SETAC.

Water pollution threats in important bird and biodiversity areas from Spain.

Chemical pollution is still an underestimated threat to surface waters from natural areas. This study has analysed the presence and distribution of 59 organic micropollutants (OMPs) including pharmaceuticals, lifestyle compounds, pesticides, organophosphate esters (OPEs), benzophenone and perfluoroalkyl substances (PFASs) in 411 water samples from 140 Important Bird and Biodiversity Areas (IBAs) from Spain, to evaluate the impact of these pollutants in sites of environmental relevance. Lifestyle compounds, pharmaceuticals and OPEs were the most ubiquitous chemical families, while pesticides and PFASs showed a detection frequency below 25% of the samples. The mean concentrations detected ranged from 0.1 to 301 ng/L. According to spatial data, agricultural surface has been identified as the most important source of all OMPs in natural areas. Lifestyle compounds and PFASs have been related to the presence of artificial surface and wastewater treatment plants (WWTPs) discharges, which were also an important source of pharmaceuticals to surface waters. Fifteen out of 59 OMPs have been found at levels posing a high risk for the aquatic IBAs ecosystems, being the insecticide chlorpyrifos, the antidepressant venlafaxine and perfluorooctanesulfonic acid (PFOS) the most concerning compounds. This is the first study to quantify water pollution in IBAs and evidence that OMPs are an emerging threat to freshwater ecosystems that are essential for biodiversity conservation.

Legacy and emerging contaminants in flamingos' chicks' blood from the Ebro Delta Natural Park.

The Ebro Delta is a wetland of international importance for waterbird conservation but severally affected by intensive agriculture, toxic waste discharges from a past chloro-alkali industry and affluence of tourism. The discharge of contaminants associated to these activities pose waterbirds breeding in the Ebro Delta at risk. The aim of this study is to evaluate the exposure of 91 emerging and legacy micropollutants in flamingo chicks (Phoenicopterus roseus), an emblematic species of the area. Fifty chicks of 45-60 days were captured, biometric parameters measured and whole blood collected. Compounds analyzed included perfluoroalkyl substances (PFASs), pharmaceuticals, organophosphate esters (OPEs), in-use pesticides, polychlorinated biphenyls (PCBs), organochlorine pesticides (OCs), and polycyclic aromatic hydrocarbons (PAHs). The results indicate a multi-exposure of flamingo's chicks from a very young age. PFASs were the most ubiquitous compounds with ∑PFASs ranging from 9.34 to 576 ng/mL, being PFOA, PFOS and PFHxS detected in all samples. ∑PAHs ranged from 0.19 to 423 ng/mL, ∑PCBs from 0.5 to 15.6 ng/mL and ∑OCs from 1.35 to 37.8 ng/mL. Pharmaceuticals, OPEs and in-use pesticides were not detected. The flamingo's filtering behavior on mud and maternal ovo-transference are the more likely routes of exposure of organic micropollutants to flamingos' chicks. The reported levels of micropollutants were not associated with any alteration in the body condition of chicks. This is the first study to describe flamingos chicks' exposure to multiple contaminants, highlighting the importance of biomonitoring for wildlife conservation and biodiversity preservation.

Multicenter Real-World Data of Subsequent Chemotherapy after Progression to PARP Inhibitors in a Maintenance Relapse Setting.

Background: Despite impressive progression-free survival (PFS) results from PARP inhibitors (PARPi) in ovarian cancer, concerns about their effect on post-progression treatment outcomes have recently arisen, particularly when administered in the relapsed setting. Overlapping mechanisms of resistance between PARPi and platinum have been described, and optimal therapies upon progression to PARPi are unknown. We communicate real-world data (RWD) on outcomes of subsequent chemotherapy upon progression to PARPi used as maintenance in ovarian cancer relapses, particularly focusing on platinum rechallenge, according to BRCA status. Methods: Data from high-grade serous or endometrioid ovarian cancer patients who received subsequent chemotherapy after progression to maintenance PARPi in the relapsed setting, in 16 Catalan hospitals between August 2016 and April 2021, and who were followed-up until July 2021, were included. Endpoints were overall response rate (ORR), and PFS and overall survival (OS) measured from the subsequent chemotherapy starting date. Results: 111 patients were included [46 (41.4%) presented pathological BRCA1/2 mutations, 8 (7.5%) in other homologous recombination-related genes]. Sixty-four patients (57.7%) had received two prior chemotherapy lines, including the one immediately prior to PARPi. PARPi were niraparib (n = 60, 54.1%), olaparib (n = 49, 44.1%), and rucaparib (n = 2, 1.8%). A total of 81 patients remained platinum-sensitive (PS population) after progression to PARPi (when progression-free interval [PFI] was >6 months after the last cycle of prior platinum) [median PFI 12.0 months (interquartile range, IQR, 8.8−17.1)]. Of those, 74 were treated with subsequent platinum regimens, with the following results: ORR of 41.9%, median PFS (mPFS) of 6.6 months (95% CI 6−9.2), and median OS (mOS) of 20.6 months (95% CI 13.6−28.9). Analysis of these 74 patients according to BRCA status showed that PFIs for BRCA mutant and non BRCA-mutant patients were 13.6 [IQR11.2−22.2] and 10.3 [IQR 7.4−14.9] months, respectively (p = 0.010); ORR were 40.0% versus 43.6%, respectively; Rates of progression (as best response) to subsequent platinum were 45.7% versus 17.9%, respectively (p = 0.004); mPFS and mOS were 3.5 (95% CI 2.5−8.6) versus 7.5 months (95% CI 6.5−10.1, p = 0.03), and 16.4 (95% CI 9.3−27.5) versus 24.2 months (95% CI 17.2−NR, p = 0.036), respectively. Conclusion: This is the largest series of real-world data on ovarian cancer patients retreated with platinum in the post-PARPi scenario, separately analyzing BRCA mutant and non-mutant patients, to our knowledge. In our platinum-sensitive population, rechallenge with platinum after progression upon PARPi in the 3rd or later lines for ovarian cancer relapses shows relevant ORR and similar PFS outcomes to historical series of the prePARPi era. However, BRCA mutant patients presented significantly higher rates of progression under subsequent platinum and worse survival outcomes associated with subsequent platinum than non-BRCA-mutant patients.

Pilot monitoring scheme of water pollutants in Important Bird and Biodiversity Areas.

In this study we have established a monitoring scheme to determine the presence and distribution of widely used pharmaceuticals, pesticides, organophosphate esters (OPEs) and perfluoroalkyl substances (PFAS) in water bodies from Important Bird and Biodiversity Areas (IBAs) from Spain. The monitoring scheme included the georeferenced sampling of rocky mountain, Atlantic forest, riparian forest, Mediterranean forest, agricultural, inland aquatic and coastal aquatic IBAs, with the aim to evaluate the impact of widely used chemicals in those aquatic resources. Water samples were extracted using a generic solid-phase extraction protocol and analyzed by 3 analytical methods based on liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). Quality parameters such as compound recovery, intra and inter-day variation, linearity and limits of detection were calculated in order to validate the methods. In addition, the ionization conditions and the optimization of the most appropriate transitions permitted unequivocal identification. Once the sampling and analytical procedure was set-up, 59 target compounds were monitored in 63 samples. Pharmaceutical, followed by pesticides, OPEs and PFAS were widespread along all IBAs studied at concentrations from 0.5 to 41083 ng/L. Overall, this study highlights the need to monitor the presence of contaminants in areas of high ecological interest to contribute to pollution control and mitigation towards protection of biodiversity.

A review of constraints and solutions for collecting raptor samples and contextual data for a European Raptor Biomonitoring Facility.

The COST Action 'European Raptor Biomonitoring Facility' (ERBFacility) aims to develop pan-European raptor biomonitoring in support of better chemicals management in Europe, using raptors as sentinel species. This presents a significant challenge involving a range of constraints that must be identified and addressed. The aims of this study were to: (1) carry out a comprehensive review of the constraints that may limit the gathering in the field of raptor samples and contextual data, and assess their relative importance across Europe; and (2) identify and discuss possible solutions to the key constraints that were identified. We applied a participatory approach to identify constraints and to discuss feasible solutions. Thirty-one constraints were identified, which were divided into four categories: legal, methodological, spatial coverage, and skills constraints. To assess the importance of the constraints and their possible solutions, we collected information through scientific workshops and by distributing a questionnaire to stakeholders in all the countries involved in ERBFacility. We obtained 74 answers to the questionnaire, from 24 of the 39 COST participating countries. The most important constraints identified were related to the collection of complex contextual data about sources of contamination, and the low number of existing raptor population national/regional monitoring schemes and ecological studies that could provide raptor samples. Legal constraints, such as permits to allow the collection of invasive samples, and skills constraints, such as the lack of expertise to practice necropsies, were also highlighted. Here, we present solutions for all the constraints identified, thus suggesting the feasibility of establishing a long-term European Raptor Sampling Programme as a key element of the planned European Raptor Biomonitoring Facility.